Cefepime
Cefepime is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Pneumonia caused by S. pneumoniae
- Including cases associated with concurrent bacteremia, P. aeruginosa, K. pneumoniaeor Enterobacter species.
- Febrile neutropenia (empiric therapy)
- Uncomplicated and complicated urinary tract infections including pyelonephritis (+/- bacteremia) caused by E. coli, K. pneumoniae, or P. mirabilis
- Uncomplicated skin and skin-structure infections caused by MSSA or S. pyogenes.
- Complicated intra-abdominal infections (in combination with metronidazole) caused by E. coli, viridans group streptococci, P. aeruginosa, K. pneumoniae, Enterobacter species, or B. fragilis.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Shunt infections, CNS
- Appendicitis (with metronidazole)
- Diverticulitis (with metronidazole)
- Intra-abdominal abscess (with metronidazole)
- Osteomyelitis, acute
- Osteomyelitis, chronic
- Diabetic foot infection (with metronidazole or clindamycin)
- Hardware associated septic arthritis
- Acute exacerbations of chronic bronchitis
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Pneumonia caused by S. pneumoniae
- Including cases associated with concurrent bacteremia, P. aeruginosa, K. pneumoniaeor Enterobacter species.
- Febrile neutropenia (empiric therapy)
- Uncomplicated and complicated urinary tract infections including pyelonephritis (+/- bacteremia) caused by E. coli, K. pneumoniae, or P. mirabilis
- Uncomplicated skin and skin-structure infections caused by MSSA or S. pyogenes.
- Complicated intra-abdominal infections (in combination with metronidazole) caused by E. coli, viridans group streptococci, P. aeruginosa, K. pneumoniae, Enterobacter species, or B. fragilis.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Shunt infections, CNS
- Appendicitis (with metronidazole)
- Diverticulitis (with metronidazole)
- Intra-abdominal abscess (with metronidazole)
- Osteomyelitis, acute
- Osteomyelitis, chronic
- Diabetic foot infection (with metronidazole or clindamycin)
- Hardware associated septic arthritis
- Acute exacerbations of chronic bronchitis
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 2, 2018
Citation
Dzintars, Kathryn, and Paul A Pham. "Cefepime." Johns Hopkins ABX Guide, The Johns Hopkins University, 2018. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540090/0.1/Cefepime.
Dzintars K, Pham PA. Cefepime. Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540090/0.1/Cefepime. Accessed March 21, 2023.
Dzintars, K., & Pham, P. A. (2018). Cefepime. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540090/0.1/Cefepime
Dzintars K, Pham PA. Cefepime [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. [cited 2023 March 21]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540090/0.1/Cefepime.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cefepime
ID - 540090
A1 - Dzintars,Kathryn,Pharm.D., BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2018/10/02/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540090/0.1/Cefepime
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -